Search results for "From Annals of Internal Medicine"
Running two tests on single blood sample could provide diabetes diagnosis
In a prospective cohort analysis of patients in the Atherosclerosis Risk in Communities study without diagnosed diabetes at baseline, both fasting glucose and HbA1c level were measured in a single blood sample taken during a visit in 1990 to 1992.
https://diabetes.acponline.org/archives/2018/07/13/6.htm
13 Jul 2018
Canagliflozin can lead to statin toxicity, case report finds
A case report describes a patient who had taken rosuvastatin for five years and had new muscle pain and difficulty ambulating two weeks after initiation of canagliflozin.
https://diabetes.acponline.org/archives/2020/08/14/6.htm
14 Aug 2020
Liraglutide provided cardiovascular benefit to oldest patients, post hoc analysis finds
Researchers analyzed the industry-funded LEADER trial, focusing on the oldest patients who were randomized to liraglutide or placebo.
https://diabetes.acponline.org/archives/2018/12/14/7.htm
14 Dec 2018
SGLT-2 inhibitor-associated ketoacidosis—a history lesson
In a new Annals On Call podcast, host Robert M. Centor, MD, MACP, analyzes ketoacidosis associated with sodium-glucose cotransporter-2 (SGLT-2) inhibitors with guest Bruce R. Leslie, MD, FACP.
https://diabetes.acponline.org/archives/2020/04/10/7.htm
10 Apr 2020
Early-onset diabetes tied to higher risk for all-cause hospitalization
Patients who were diagnosed with diabetes before age 40 years had significantly higher risk of hospitalization for renal, cardiovascular, and infectious causes, but this was reduced with good risk factor control.
https://diabetes.acponline.org/archives/2019/02/08/6.htm
8 Feb 2019
Beyond the Guidelines: Should we screen for type 2 diabetes?
Whether to screen a patient for type 2 diabetes is the focus of a Beyond the Guidelines feature in the Oct. 4 Annals of Internal Medicine.
https://diabetes.acponline.org/archives/2016/10/07/6.htm
7 Oct 2016
VA and DoD offer guideline on managing type 2 diabetes with summary in Annals
The summary describes ways in which the Veterans Affairs/Department of Defense (VA/DoD) guideline differs from recommendations from the American Diabetes Association, the American Geriatrics Society, and the American Association of Clinical Endocrinologists.
https://diabetes.acponline.org/archives/2017/11/10/5.htm
10 Nov 2017
Diabetes drug classes associated with similar outcomes in low-risk patients
A systematic review and network meta-analysis found no differences between treatments for drug-naive patients with type 2 diabetes at low cardiovascular risk, leading the authors to conclude that metformin is justified as a first-line therapy.
https://diabetes.acponline.org/archives/2020/07/10/6.htm
10 Jul 2020
Metformin use associated with improved outcomes in patients with historical contraindications
A systematic review found that metformin appeared to be associated with lower all-cause mortality in patients with moderate chronic kidney disease, congestive heart failure, or chronic liver disease with hepatic impairment.
https://diabetes.acponline.org/archives/2017/01/13/5.htm
13 Jan 2017
Synopsis covers ADA update on pharmaceutical management of type 2 diabetes
Experts summarized the latest guidance on medication therapy from the American Diabetes Association (ADA) in a recent article.
https://diabetes.acponline.org/archives/2020/09/11/6.htm
11 Sep 2020